by According to Precedence Research, during the forecast period of 2022 to 2030, the global dental biomaterials market is estimated to develop at a compound annual growth rate (CAGR) of 6.8%. The global dental biomaterials market was valued at USD 7.96 billion in 2021, and it is predicted to exceed USD 13.6 billion by 2030. The study investigates several elements and their consequences on the growth of the dental biomaterials market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1684
This report focuses on dental biomaterials market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall dental biomaterials market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the Dental Biomaterials Market
| Report Coverage | Details |
| Market Size by 2030 | USD 13.6 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 6.8% |
| North America Market Share in 2021 | 37% |
| Dental Laboratories Segment Market Share in 2021 | 38% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, Application, End Use, Bone Graft Material Type, Geography |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of dental biomaterials, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of dental biomaterials has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the dental biomaterials market.
Some of the prominent players in the dental biomaterials market include:
- 3M Company
- Bego Medical GmbH
- Carpenter Technology Corporation
- Danaher Corporation
- Datum Dental Ltd.
- GC Corporation
- Henry Schein Inc.
- IvoclarVivadent AG
- Keystone Dental Inc.
- Medtronic PLC
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1684
Segments Covered in the Report
By Type
- Metallic Biomaterials
- Titanium
- Stainless Steel
- Chromium Alloys
- Other Metallic
- Ceramic Biomaterials
- Polymeric Biomaterials
- Metal-Ceramic Biomaterials
- Natural Biomaterials
- Composites Biomaterials
By Application
- Implantology
- Orthodontics
- Prosthodontics
- Others
By End Use
- Dental Hospitals and Clinics
- Dental Laboratories
- Dental Academics and Research Institutes
- Dental Product Manufacturers
By Bone Graft Material Type
- Allograft
- Xenograft
- Synthetic
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Dental Biomaterials Market
5.1. COVID-19 Landscape: Dental Biomaterials Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Dental Biomaterials Market, By Type
8.1. Dental Biomaterials Market, by Type, 2022-2030
8.1.1. Metallic Biomaterials
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Ceramic Biomaterials
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Polymeric Biomaterials
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Metal-Ceramic Biomaterials
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Natural Biomaterials
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Composites Biomaterials
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dental Biomaterials Market, By Application
9.1. Dental Biomaterials Market, by Application, 2022-2030
9.1.1. Implantology
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Orthodontics
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Prosthodontics
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Dental Biomaterials Market, By End Use Type
10.1. Dental Biomaterials Market, by End Use Type, 2022-2030
10.1.1. Dental Hospitals and Clinics
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Dental Laboratories
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Dental Academics and Research Institutes
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Dental Product Manufacturers
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Dental Biomaterials Market, By Bone Graft Material Type
11.1. Dental Biomaterials Market, by Bone Graft Material Type, 2022-2030
11.1.1. Allograft
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Xenograft
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Synthetic
11.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Dental Biomaterials Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.1.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.1.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.2.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.7.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.2.8.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.3.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.7.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.3.8.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.4.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.7.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
12.4.8.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.5.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
12.5.6.3. Market Revenue and Forecast, by End Use Type (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Bone Graft Material Type Type (2017-2030)
Chapter 13. Company Profiles
13.1. 3M Company
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bego Medical GmbH
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Carpenter Technology Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Danaher Corporation
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Datum Dental Ltd.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GC Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Henry Schein Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. IvoclarVivadent AG
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Keystone Dental Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Medtronic PLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1684
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
